August 24th, 2018
•Here we present a protocol to differentiate retinal pigment epithelium (RPE) cells from human pluripotent stem cells bearing patient-derived mutations. The mutant cell lines may be used for functional analyses including immunoblotting, immunofluorescence, and patch clamp. This disease-in-a-dish approach circumvents the difficulty of obtaining native human RPE cells.
Tags
Related Videos
Analysis of Cap-binding Proteins in Human Cells Exposed to Physiological Oxygen Conditions
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9
CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans
Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets
Identifying Mutations by High Resolution Melting in a TILLING Population of Rice
Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved